NCT05103943View on ClinicalTrials.gov

Amyloidosis TTR Flow Reserve Evaluation

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Amyloid Cardiomyopathy
Interventions
OTHER

SPECT MPI

SPECT MPI including dynamic acquisitions for stress, rest MBF and MFR

Trial Locations (3)

45067

CHR d'Orleans, Orléans

Unknown

CHU d'ANGERS, Angers

CHRU de TOURS, Tours

All Listed Sponsors
lead

Centre Hospitalier Régional d'Orléans

OTHER